Results 201 to 210 of about 84,856 (259)

Secondary Sclerosing Cholangitis (SSC): An Underrecognized Complication of Severe COVID-19 Pneumonitis. [PDF]

Cureus
Pogorelova M, Kusztos V.
europepmc   +1 more source

Limited validity of Mayo endoscopic subscore in ulcerative colitis with concomitant primary sclerosing cholangitis. [PDF]

World J Gastrointest Endosc
Wohl P, Krausova A, Wohl P, Fabian O, Bajer L, Brezina J, Drastich P, Hlavaty M, Novotna P, Kahle M, Spicak J, Gregor M.   +11 more
europepmc   +1 more source

Assessing brodalumab in the treatment of primary sclerosing cholangitis (SABR-PSC pilot study): protocol for a single-arm, multicentre, pilot study. [PDF]

BMJ Open Gastroenterol
Elzubeir A, High J, Hammond M, Shepstone L, Pond M, Walmsley M, Trivedi P, Culver E, Aithal G, Dyson J, Thorburn D, Alexandre L, Rushbrook S.   +12 more
europepmc   +1 more source

Multiple intrahepatic artery aneurysms during the treatment for IgG4-related sclerosing cholangitis: A case report. [PDF]

World J Hepatol
Tamura H, Ozono Y, Uchida K, Uchiyama N, Hatada H, Ogawa S, Iwakiri H, Kawakami H.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis

Gut, 2021
Objective Multiple clinical similarities exist between IgG4-related sclerosing cholangitis (IgG4-SC) and primary sclerosing cholangitis (PSC), and while gut dysbiosis has been extensively studied in PSC, the role of the gut microbiota in IgG4-SC remains ...
Qiaoyan Liu, Bo Li, Yikang Li, Yiran Wei, Bingyuan Huang, Jubo Liang, Z. You, You Li, Qiwei Qian, Rui Wang, Jun Zhang, Ruiling Chen, Zhuwan Lyu, Yong Chen, M. Shi, Xiao Xiao, Qixia Wang, Q. Miao, J. Fang, M. Gershwin, M. Lian, Xiong Ma, R. Tang   +22 more
semanticscholar   +1 more source

Geniposide suppresses liver injury in a mouse model of DDC‐induced sclerosing cholangitis

Phytotherapy Research, 2021
Sclerosing cholangitis, characterized by biliary inflammation, fibrosis, and stricturing, remains one of the most challenging conditions of clinical hepatology. Geniposide (GE) has anti‐inflammatory, hepatoprotective, and cholagogic effects.
Min Wen, Yubei Liu, Ruiying Chen, P. He, Feihua Wu, Rui Li, Yining Lin   +6 more
semanticscholar   +1 more source

Primary sclerosing cholangitis

Current Problems in Surgery, 1992
Primary sclerosing cholangitis (PSC) is an inflammatory disease of unknown etiology. It affects the biliary system and is characterized by fibrosis and progressive obliteration of extrahepatic and intrahepatic bile ducts. Its frequent coexistence with antibody-mediated diseases, certain human leukocyte antigens, and altered lymphocyte mechanisms ...
F M, Martin, J W, Braasch
openaire   +4 more sources

Sclerosing cholangitis

Current Opinion in Gastroenterology, 2002
Primary sclerosing cholangitis in children can mimic autoimmune hepatitis in the absence of inflammatory bowel disease. Most adult patients have been identified with human leukocyte antigens that either predispose or protect against disease. Novel class I alleles and cytokine polymorphisms may also contribute to disease susceptibility.
Jayant A, Talwalkar, Keith D, Lindor
openaire   +2 more sources